Blair William & Co
- SEC CIK
- 0000902367
- Latest filing
- Aug 11, 2026
DXCM holding history
Dexcom Inc in every 13F filed by Blair William & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DXCM overviewAll 13F holders of DXCMFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,665,665
- Value
- $112.2M
- % of portfolio
- 0.3%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,665,665 | $112.2M | 0.3% | −261,722−13.6% | Reduced | Holders |
| Q1 2026 | 1,927,387 | $121.0M | 0.3% | −61,454−3.1% | Reduced | Holders |
| Q4 2025 | 1,988,841 | $132.0M | 0.4% | −120,502−5.7% | Reduced | Holders |
| Q3 2025 | 2,109,343 | $141.9M | 0.4% | −98,701−4.5% | Reduced | Holders |
| Q2 2025 | 2,208,044 | $192.7M | 0.5% | −30,519−1.4% | Reduced | Holders |
| Q1 2025 | 2,238,563 | $152.9M | 0.5% | +5,916+0.3% | Added | Holders |
| Q4 2024 | 2,232,647 | $173.6M | 0.5% | −509,462−18.6% | Reduced | Holders |
| Q3 2024 | 2,742,109 | $183.8M | 0.5% | −1,557,310−36.2% | Reduced | Holders |
| Q2 2024 | 4,299,419 | $487.5M | 1.5% | −233,268−5.1% | Reduced | Holders |
| Q1 2024 | 4,532,687 | $628.7M | 2.0% | +64,683+1.4% | Added | Holders |
| Q4 2023 | 4,468,004 | $554.4M | 1.9% | −39,149−0.9% | Reduced | Holders |
| Q3 2023 | 4,507,153 | $420.5M | 1.6% | +73,654+1.7% | Added | Holders |
| Q2 2023 | 4,433,499 | $569.7M | 2.1% | +77,048+1.8% | Added | Holders |
| Q1 2023 | 4,356,451 | $506.1M | 2.0% | −64,976−1.5% | Reduced | Holders |
| Q4 2022 | 4,421,427 | $500.7M | 2.2% | −200,321−4.3% | Reduced | Holders |
| Q3 2022 | 4,621,748 | $372.2M | 1.7% | +119,780+2.7% | Added | Holders |
| Q2 2022 | 4,501,968 | $335.5M | 1.5% | −138,812−3.0% | ReducedConverted for a 4-for-1 split | Holders |
| Q1 2022 | 1,160,195 | $593.6M | 2.1% | −19,462−1.6% | Reduced | Holders |
| Q4 2021 | 1,179,657 | $633.4M | 2.0% | −23,420−1.9% | Reduced | Holders |
| Q3 2021 | 1,203,077 | $657.9M | 2.2% | −3,705−0.3% | Reduced | Holders |
| Q2 2021 | 1,206,782 | $515.3M | 1.8% | +20,119+1.7% | Added | Holders |
| Q1 2021 | 1,186,663 | $426.5M | 1.6% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.